![](/img/cover-not-exists.png)
EV-201: Long-term results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and PD-1/PD-L1 inhibitors
O'Donnell, P., Galsky, M.D., Rosenberg, J.E., Petrylak, D.P., Balar, A.V., McGregor, B.A., Heath, E., Yu, E.Y., Quinn, D.I., Hahn, N.M., Campbell, M., Liang, S-Y., Steinberg, J., Loriot, Y.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.818
Date:
September, 2020
File:
PDF, 96 KB
2020